Pusceddu, S.
223  results:
Search for persons X
?
 
?
4

Second primary neoplasms in patients with lung and gastroen..:

Massironi, S. ; Campana, D. ; Pusceddu, S....
Digestive and Liver Disease.  53 (2021)  3 - p. 367-374 , 2021
 
?
6

Impact of the SARS-CoV2 pandemic dissemination on the manag..:

Panzuto, F. ; Maccauro, M. ; Campana, D....
Journal of Endocrinological Investigation.  44 (2020)  5 - p. 989-994 , 2020
 
?
7

T03.01.15 SECOND PRIMARY NEOPLASMS IN PATIENTS WITH GASTRO-..:

Massironi, S. ; Campana, D. ; Pusceddu, S....
Digestive and Liver Disease.  52 (2020)  - p. S100-S101 , 2020
 
?
 
?
9

P.04.17 EFFECTS OF LOW-DOSES ASPIRIN ON CLINICAL OUTCOME AN..:

Massironi, S. ; Pusceddu, S. ; Cavalcoli, F....
Digestive and Liver Disease.  50 (2018)  2 - p. e162-e163 , 2018
 
?
10

Primary tumour resection may improve survival in functional..:

Citterio, D. ; Pusceddu, S. ; Facciorusso, A....
European Journal of Surgical Oncology (EJSO).  43 (2017)  2 - p. 380-387 , 2017
 
?
11

6626 POSTER Efficacy and Safety of RAD001 as Second Line Th..:

Buzzoni, R. ; Pusceddu, S. ; Biondani, P....
European Journal of Cancer.  47 (2011)  - p. S479-S480 , 2011
 
?
12

Gender-related differences in patients with carcinoid syndr..:

Ruggeri, R M ; Altieri, B ; Razzore, P...
info:eu-repo/semantics/altIdentifier/pmid/37837555.  , 2023
 
?
13

Gender-related differences in patients with carcinoid syndr..:

Ruggeri, R M ; Altieri, B ; Razzore, P...
info:eu-repo/semantics/altIdentifier/pmid/37837555.  , 2023
 
?
14

Assessment of the Risk of Nodal Involvement in Rectal Neuro..:

Ricci A. D ; Pusceddu S ; Panzuto F...
info:eu-repo/semantics/altIdentifier/pmid/35160165.  , 2022
 
?
15

Association of Upfront Peptide Receptor Radionuclide Therap..:

Pusceddu S ; Prinzi N ; Tafuto S...
info:eu-repo/semantics/altIdentifier/pmid/35201309.  , 2022
 
1-15